Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors

被引：0
|
作者：
B. Schultheis
G. Kummer
M. Zeth
E. Brendel
C. Xia
M. Kornacker
D. Strumberg
机构：
[1] University of Bochum (Marienhospital Herne),Department of Haematology and Medical Oncology
[2] Bayer HealthCare Pharmaceuticals,undefined
[3] Bayer HealthCare Pharmaceuticals,undefined
[4] Bayer HealthCare Pharmaceuticals,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Phase I; Sorafenib; Gemcitabine; Cisplatin; Multiple kinase inhibitor; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：333 / 339
页数：6
相关论文
共 50 条
  • [21] Phase I trial of everolimus, gemcitabine and cisplatin for patients with solid tumors refractory to standard therapy.
    Costello, Brian Addis
    Qi, Yingwei
    Borad, Mitesh J.
    Kim, George P.
    Northfelt, Donald W.
    Erlichman, Charles
    Alberts, Steven R.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] Phase I study of a 3-drug combination of gemcitabine, vinorelbine and cisplatin (GVP) in patients (PTS) with solid tumors
    Rasschaert, Marika A.
    Pauwels, Bea
    Corthouts, Bob
    Van den Brande, Jan
    Schrijvers, Dirk
    Vermorken, Jan B.
    ANNALS OF ONCOLOGY, 2006, 17 : 142 - 142
  • [23] A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.
    Schrijvers, D
    Dyck, J
    Van den Brande, J
    Wilmes, P
    Korst, A
    Lardon, F
    Vermorken, J
    ANNALS OF ONCOLOGY, 2000, 11 : 140 - 140
  • [24] Phase I, Pharmacogenomic, Drug Interaction Study of Sorafenib and Bevacizumab in Combination with Paclitaxel in Patients with Advanced Refractory Solid Tumors
    Chiorean, E. Gabriela
    Perkins, Susan M.
    Strother, R. Matthew
    Younger, Anne
    Funke, Jennifer M.
    Shanda, Safi G.
    Hahn, Noah M.
    Sandrasegaran, Kumar
    Jones, David R.
    Skaar, Todd C.
    Schneider, Bryan P.
    Sweeney, Christopher J.
    Matei, Daniela E.
    MOLECULAR CANCER THERAPEUTICS, 2020, 19 (10) : 2155 - 2162
  • [25] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Plummer, Ruth
    Madi, Ayman
    Jeffels, Melinda
    Richly, Heike
    Nokay, Bahar
    Rubin, Stephen
    Ball, Howard A.
    Weller, Steve
    Botbyl, Jeffrey
    Gibson, Diana M.
    Scheulen, Max E.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (01) : 93 - 101
  • [26] A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors
    Ruth Plummer
    Ayman Madi
    Melinda Jeffels
    Heike Richly
    Bahar Nokay
    Stephen Rubin
    Howard A. Ball
    Steve Weller
    Jeffrey Botbyl
    Diana M. Gibson
    Max E. Scheulen
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 93 - 101
  • [27] A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Akiyoshi Kasuga
    Kazuhiko Nakagawa
    Fumio Nagashima
    Toshio Shimizu
    Daisuke Naruge
    Shinichi Nishina
    Hiroshi Kitamura
    Takayasu Kurata
    Atsuko Takasu
    Yasuhito Fujisaka
    Wataru Okamoto
    Yuichiro Nishimura
    Akihira Mukaiyama
    Hideki Matsushita
    Junji Furuse
    Investigational New Drugs, 2015, 33 : 1058 - 1067
  • [28] A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumors
    Kasuga, Akiyoshi
    Nakagawa, Kazuhiko
    Nagashima, Fumio
    Shimizu, Toshio
    Naruge, Daisuke
    Nishina, Shinichi
    Kitamura, Hiroshi
    Kurata, Takayasu
    Takasu, Atsuko
    Fujisaka, Yasuhito
    Okamoto, Wataru
    Nishimura, Yuichiro
    Mukaiyama, Akihira
    Matsushita, Hideki
    Furuse, Junji
    INVESTIGATIONAL NEW DRUGS, 2015, 33 (05) : 1058 - 1067
  • [29] Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors
    Marme, F.
    Gomez-Roca, C.
    Graudenz, K.
    Huang, F.
    Lettieri, J.
    Pena, C.
    Trnkova, Z.
    Eucker, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [30] Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors
    Meany, Holly J.
    Widemann, Brigitte C.
    Hinds, Pamela S.
    Bagatell, Rochelle
    Shusterman, Suzanne
    Stern, Emily
    Jayaprakash, Nalini
    Peer, Cody J.
    Figg, William D.
    Hall, O. Morgan
    Sissung, Tristan M.
    Kim, Aerang
    Fox, Elizabeth
    London, Wendy B.
    Rodriguez-Galindo, Carlos
    Minturn, Jane E.
    Dome, Jeffrey S.
    PEDIATRIC BLOOD & CANCER, 2021, 68 (11)
12345